Randomized phase 2 study of fludarabine with concurrent versus sequential treatment with rituximab in symptomatic, untreated patients with B-cell chronic lymphocytic leukemia: results from Cancer and Leukemia Group B 9712 (CALGB 9712).
published in: Blood
date of publication: 2002-07-05
language: English
main subject: lymphocyte, patient, leukemia, B-cell chronic lymphocytic leukemia, rituximab
Cites articles
There is nothing here
Article - wd:Q34155712